Fmoc-Lys(Pal-Glu-OtBu)-OH is a protected amino acid derivative used as a pharmaceutical intermediate. Its structure features a palmitoyl chain, a glutamate residue with a tert-butyl ester protecting group, and an Fmoc-protected lysine backbone, making it suitable for solid-phase peptide synthesis.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1491158-62-3
Fmoc-Lys[|A-Glu(OtBu)-C18-OtBu)]-OH
solid phase peptide synthesis reagent
Fmoc-L-Lys[C20-OtBu-L-Glu(OtBu)-AA-AA]-OH
Pharmaceutical intermediate for peptide synthesis
(3R,4S)-tert-Butyl 2-oxo-4-phenyl-3-(triethylsilyloxy)azetidine-1-carboxylate
Pharmaceutical intermediate for beta-lactam synthesis
(3R,4S)-1-BENZOYL-4-PHENYL-3-[(TRIETHYLSILYL)OXY]-2-AZETIDINONE
Key intermediate for Taxol synthesis
1-Fluoro-2-nitrobenzene
Pharmaceutical intermediate
Tert-butyl N-[(pyrrolidin-3-yl)methyl]carbamate
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4S)-4-(hexadecanoylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]amino]hexanoic acid
LQQXBYSAGYOQJW-ZAQUEYBZSA-N
CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C